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Introduction: Congenital coronary artery fistula is a rare anomaly that may cause angina, atrial fibrillation, endocarditis,
aneurysmal dilation and myocardial infarction. Both spontaneous regression and life-threatening complications have
been described. Treatment can be conservative, surgical or more recently through transcatheter closure.
Case presentation: We report the case of a 27-year-old Tunisian man with a large coronary artery fistula from the left
anterior descending artery to the right ventricle associated with pulmonary stenosis. This patient underwent a
successful transcatheter closure of his coronary artery fistula followed by pulmonary dilatation and had an uneventful
recovery after treatment.
Conclusions: Transcatheter closure of a congenital coronary artery fistula is feasible and should be considered in
carefully selected patients. Recanalization of the treated coronary fistula can occur, so follow-up angiography or other
imaging modality should be performed in these patients.
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Congenital coronary artery fistulas (CAFs) are abnormal
connections between either or both coronary arteries
and a cardiac chamber or a great vessel. The drainage of
these fistulas is more typically to the right atrium, right
ventricle, or right atrium-superior vena cava junction,
and occasionally to the coronary sinus or left side of the
heart. A congenital CAF is a rare anomaly with a 0.2%
to 0.6% incidence in angiographic series and 0.002%
overall incidence in the general population [1,2]. Con-
genital CAFs can be single or multiple, and may be asso-
ciated with other cardiac abnormalities. Approximately
10% to 30% of patients with a CAF also have another
congenital cardiovascular anomaly [3,4]. The most com-
monly seen defects include variations of tetralogy of
Fallot, patent ductus arteriosus, atrial septal defect,
ventricular septal defect and pulmonary stenosis. Con-
ventional coronary angiography is a commonly used
diagnostic modality for tracing the anatomic course of
coronary fistulas. Computed tomography (CT) angiog-
raphy is also an important tool for defining size, anat-
omy and the relation of the CAFs to adjacent structures* Correspondence: mehdislim_fms@yahoo.fr
Department of Cardiology, Sahloul University Hospital, Hammam Sousse,
Route de la Ceinture, 4011 Sousse, Tunisia
© 2014 Gribaa et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.[5]. Most patients are asymptomatic. However, a CAF
may cause heart failure secondary to volume overload
resulting from left to right shunting, ischemia secondary
to coronary steal, arrhythmia, fistula rupture or throm-
bosis, and infective endocarditis [6]. That is why closure
of large CAFs is indicated to prevent these complica-
tions. The American College of Cardiology/American
Heart Association (2008) guidelines for the management
of adults with congenital heart disease recommend clos-
ure of all large CAFs, regardless of symptoms, using
transcatheter or surgical techniques [7]. Since the first
percutaneous closure performed in 1983 [8], numerous
reports of transcatheter closure have been described. We
report the case of a patient who underwent successful
transcatheter closure of a CAF followed by pulmonary
dilatation.
Case presentation
We report the case of a 27-year-old Tunisian man who
presented with dyspnea (New York Heart Association
(NYHA) functional class II) associated with typical an-
gina. He has a medical history of ventricular septal
defect associated with pulmonary stenosis diagnosed at
15 years old, with surgical treatment refused by his
parents and with interrupted follow-up since then.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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grade 3/6 systolic murmur over the second left intercos-
tal space without signs of heart failure or cyanosis. His
electrocardiogram showed sinus rhythm with incomplete
right bundle branch block. His chest X-ray showed
cardiomegaly and dilatation of his left pulmonary artery.
Transthoracic echocardiography showed normal left ven-
tricular systolic function without wall motion abnormal-
ities. The right ventricle was hypertrophied, dilated but
with normal contractility. Severe pulmonary valvular sten-
osis was also visualized. An exploration of the ventricular
septum showed a closed ventricular septal defect without
evidence of shunt, related to a spontaneous closure of the
defect. Cardiac catheterization confirmed a tight valvular
pulmonary stenosis with systolic right ventricular and pul-
monary arterial pressures at 103 and 14mmHg respect-
ively, resulting in a 95mmHg systolic gradient between the
right ventricle and pulmonary artery. Selective pulmonary
angiography showed a severe valvular pulmonary stenosis
and a left pulmonary artery stenosis with a poststenotic
aneurysm. Left ventricle angiography showed a 12mm
ventricular septal defect completely closed and an aneur-
ismal left coronary artery. Selective coronary angiography
revealed a dilated left coronary artery and 3mm coronary
fistula arising from the mid segment of the left anterior
descending artery (LAD) to the right ventricle (RV) with
occlusion of the distal LAD (Figure 1). Percutaneous treat-
ment of both lesions was decided starting with the CAF to
prevent acute myocardial ischemia that may appear after
acute coronary steal consequent to the decrease of the RV
pressure after relief of the pulmonary obstruction. A suc-
cessful transcatheter closure of the fistula using a 4/6
Amplatzer™ duct occluder II (ADO II) was achieved, with
partial reopening of the fistula on the following day
(Figure 2). No electrocardiogram changes were observed
during or after the procedure. Heparin therapy wasFigure 1 Selective coronary angiography showing a coronary artery f
artery draining into the right ventricle. Anterior oblique 90 degree view
38 degree and right anterior oblique 12 degree view (Panel 1C).started with 150mg aspirin and 75mg clopidogrel to
prevent thrombosis of the occluded vessel and discon-
tinued after evidence of partial reopening of the fistula
on systematic echocardiography control performed 24
hours after the procedure.
Serial electrocardiograms documented normal tracings
without evidence of ischemia. Echocardiography showed
normal left ventricular function with no pericardial effu-
sion, allowing discharge 48 hours after the procedure.
Our patient was on 150mg aspirin per day. Complete
closure of the fistula was documented nine months later
(Figure 3) allowing a successful percutaneous treatment
of the pulmonary stenosis, with reduction of the pulmon-
ary gradient from 100 to 35mmHg, using a 23/40mm
balloon, with an uneventful recovery after treatment.
Discussion
The management strategy of patients with a CAF de-
pends on the size and the anatomy of the fistula, pres-
ence of symptoms, the patient’s age and whether the
patient has other associated cardiovascular disorders. As
recommended by the American College of Cardiology/
American Heart Association (2008) guidelines [7], small
fistulas discovered incidentally in asymptomatic patients
should not be treated. However, periodic clinical evalu-
ation with imaging such as echocardiography to assess
both the size of the fistula and ventricular function is
indicated. In fact, small fistulas may slowly increase in
size with advancing age and changes in systemic blood
pressure and aortic compliance and may subsequently
require treatment [9]. Large and small-to-moderate con-
genital CAFs with suitable anatomy, without other com-
plex cardiac lesions and in the presence of symptoms of
myocardial ischemia, threatening arrhythmia, unexplained
ventricular dysfunction, or left atrial hypertension, must
be closed using transcatheter or surgical techniques. Theistula arising from the segment of the left anterior descending
(Panel 1A). Right anterior oblique 38 degree view (Panel 1B). Cranial
Figure 2 Transcatheter closure of the fistula. The Amplatzer™ duct occluder is shown in place while it is still connected to the delivery guidewire
(left anterior oblique view) (Panel 2A). Angiography confirming complete occlusion following deployment of the Amplatzer™ Duct Occluder (left anterior
oblique view) (Panel 2B). Angiography showing the device in place and residual flow through the device (left anterior oblique view) (Panel 2C).
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et al. [10] in 1947.
Since then, surgical closure of a CAF is the only op-
tion but should be performed by surgeons with training
and expertise [7]. The disadvantages of surgery are bleed-
ing, postpericardiotomy syndrome, myocardial infarction
and recurrence. Furthermore, surgery requires a median
sternotomy and sometimes cardiopulmonary bypass. In
the surgical literature [3], the rate of mortality is low (1%),
cardiopulmonary bypass was used in approximately one-
half of the cases [11,12], the rate of incomplete closure or
recurrence of fistulas was approximately 10%. Cheung
et al. reported a series of 41 patients [3] who had CAFs
treated by surgery, 21 patients had undergone cardiac
catheterization in the follow-up, four (19%) of them had
residual or recurrent fistulas. Other rare complications, in-
cluding arrhythmias, myocardial infarctions, stroke, and
ST-/T-wave changes on the electrocardiogram, were re-
ported. The first transcatheter closure was performed byFigure 3 Angiography showing residual flow through the device. Cran
The same angiographic view showing complete occlusion of the fistula aftReidy et al. [8] in 1983. Since then numerous reports of
transcatheter closure have been described [13,14]. Criteria
for transcatheter closure are similar to those used for sur-
gical closure. It should be done only in centers with par-
ticular expertise in such interventions [7]. The approach
involves several techniques and devices, including coils,
detachable balloons, covered stents, vascular plugs, and
atrial septal defect devices [15], but controversy remains
as to the best approach. In comparison with many devices
used to close CAFs, the Amplatzer™ duct occluder (ADO)
has several advantages, including the use of a single de-
vice, a high rate of complete occlusion, and improved con-
trol over placement and release of the device. The ADO II
is a modification of the ADO I and has several advantages
over it. The device stretches to accommodate different
lengths and angles. It is a flexible and low-profile occluder
(composed of multiple layers of fine nitinol braiding with-
out fabric), highly conformable to the anatomy (with
articulating ‘necks’), offers secure device placement, andial 38 degree and right anterior oblique 12 degree view (Panel 3A).
er nine months (Panel 3B).
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trackability [16]. For these reasons, we opted for the ADO
II device.
The advantages of transcatheter closure include less
morbidity, lower cost, shorter recovery time, and avoid-
ance of thoracotomy and cardiopulmonary bypass [13].
The procedural complications include transient ischemic
changes, unretrieved device embolization, fistula dissection,
myocardial infarction, and transient atrial arrhythmia [14].
In our case, the choice between transcatheter closure of the
fistula and surgical intervention was controversial. Despite
the association of fistula and severe pulmonary stenosis, we
treated our patient using the transcatheter technique. In
fact, the anatomy of the fistula and the valvular pulmonary
stenosis were suitable for percutaneous treatment, a more
low-risk procedure than surgery.
The transcatheter pulmonary dilatation was performed
after complete regression of the residual shunt. In the
literature, several reports have evaluated the efficacy and
safety of transcatheter closure of a CAF. Although, most
of the series report an excellent procedural success rate,
there is limited information about the short- and long-
term prognosis of transcatheter-treated patients with a
CAF [15,17]. Armsby and colleagues reported short-term
findings in 33 patients who underwent transcatheter clos-
ure [16]. After median follow-up, only five patients had
small residual shunts. Zhu et al. [18] reported transcathe-
ter closure results of 24 patients. All patients were asymp-
tomatic with complete closure of the CAF except for one
patient (5%), who had a recurrence of shunt at six-month
follow-up, which was re-closed by percutaneous tech-
nique. Jama et al. [15] reported transcatheter closure re-
sults of 29 patients with immediate successful closure in
all patients. Ten (56%) of the 18 patients with follow-up
angiography had no recanalization of embolized vessels;
four patients (22%) had trivial recanalization, and four
patients (22%) had large recanalizations, which were
re-closed by percutaneous technique. In our case, we
performed an immediate successful closure of the fis-
tula without any procedural complication. The early
recurrence of mild shunt was due to the combination
of heparin and double platelet aggregation inhibitors
during the first 24 hours of the procedure. This initial
residual shunting disappeared completely during the
follow-up.Conclusions
The successful results of the percutaneous closure of
coronary artery fistula in our patient suggest that this
technique is feasible and is a safe alternative to surgical
ligation. The standardization of this approach requires
study of a greater number of cases with longer follow-up
periods.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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